Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.

Autor: Yildirim HC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kapar C; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Sanci PC; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Guliyev M; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Perkin P; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Buyukkor M; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Yaslikaya S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Majidova N; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Keskinkilic M; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Ozaskin D; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Avci T; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Gunes TK; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Arcagok M; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey., Topal A; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Keskin GSY; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Kavgaci G; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Celayir OM; Department of Medical Oncology, Acibadem University Faculty of Medicine, Istanbul, Turkey., Avci N; Department of Medical Oncology, Medicana Hospital, Bursa, Turkey., Aslan F; Department of Medical Oncology, Medical Park Ankara Hospital, Ankara, Turkey., Alkan A; Department of Medical Oncology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, Turkey., Erciyestepe M; Department of Medical Oncology, Istanbul Prof. Dr. Cemil Tascioglu State Hospital, Istanbul, Turkey., Cengiz M; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Pehlivan M; Department of Medical Oncology, Zonguldak Ataturk State Hospital, Zonguldak, Turkey., Gulmez A; Department of Medical Oncology, Adana City Education and Research Hospital, Adana, Turkey., Beypinar I; Department of Medical Oncology, Alaaddin Keykubat University Faculty of Medicine, Antalya, Turkey., Basoglu Tuylu T; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kayikcioglu E; Department of Medical Oncology, Isparta Suleyman Demirel University Faculty of Medicine, Isparta, Turkey., Chalabiyev E; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Turhal S; Department of Medical Oncology, Anadolu Health Center, Istanbul, Turkey., Guzel HG; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ayas E; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Sahbazlar M; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Dulgar O; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Demir H; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Yavuzsen T; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Bayoglu V; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Kivrak Salim D; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozturk B; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozdemir F; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Kara O; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Oksuzoglu B; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Bal O; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Demirci NS; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Yilmaz M; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Cabuk D; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Mar 18, pp. 1-7. Date of Electronic Publication: 2024 Mar 18.